470 related articles for article (PubMed ID: 33412828)
41. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
42. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
43. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
[TBL] [Abstract][Full Text] [Related]
44. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
45. Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).
Bucchi L; Frigerio A; Zorzi M; Fedato C; Angiolucci G; Bernardi D; Campari C; Crocetti E; Ferretti S; Giorgi D; Marchisio F; Morrone D; Naldoni C; Petrella M; Ponti A; Ravaioli A; Saguatti G; Santini D; Sassoli de Bianchi P; Serafini M; Vergini V; Giordano L
Epidemiol Prev; 2015; 39(3 Suppl 1):52-7. PubMed ID: 26405777
[TBL] [Abstract][Full Text] [Related]
46. Are smokers less likely to seek preventive healthcare measures in Italy?
Carreras G; Iannucci L; Costa G; Chellini E; Gorini G
Eur J Cancer Prev; 2018 Sep; 27(5):507-513. PubMed ID: 28379886
[TBL] [Abstract][Full Text] [Related]
47. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
Chung A; Chen Q; Curry W; Felix T; Tuan WJ
Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
[TBL] [Abstract][Full Text] [Related]
48. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
49. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
[TBL] [Abstract][Full Text] [Related]
50. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of Cancer Screening Among Adults With Disabilities, United States, 2013.
Steele CB; Townsend JS; Courtney-Long EA; Young M
Prev Chronic Dis; 2017 Jan; 14():E09. PubMed ID: 28125399
[TBL] [Abstract][Full Text] [Related]
52. Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM.
Pediconi F; Galati F; Bernardi D; Belli P; Brancato B; Calabrese M; Camera L; Carbonaro LA; Caumo F; Clauser P; Girardi V; Iacconi C; Martincich L; Panizza P; Petrillo A; Schiaffino S; Tagliafico A; Trimboli RM; Zuiani C; Sardanelli F; Montemezzi S
Radiol Med; 2020 Oct; 125(10):926-930. PubMed ID: 32661780
[TBL] [Abstract][Full Text] [Related]
53. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
Amboree TL; Montealegre JR; Parker SL; Garg A; Damgacioglu H; Schmeler KM; Chiao EY; Hill EG; Sonawane K; Deshmukh AA; Adsul P
JAMA Intern Med; 2024 Jun; 184(6):671-679. PubMed ID: 38683574
[TBL] [Abstract][Full Text] [Related]
54. Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
Pala L; Conforti F; Saponara M; De Pas T; Giugliano F; Omodeo Salè E; Jemos C; Rubatto M; Agostini A; Quaglino P; Fava P; Fierro MT; Queirolo P
Semin Oncol; 2020 Oct; 47(5):302-304. PubMed ID: 32883537
[TBL] [Abstract][Full Text] [Related]
55. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
[No Abstract] [Full Text] [Related]
56. Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance.
Venturelli F; Sampaolo L; Carrozzi G; ; Zappa M; Giorgi Rossi P
Prev Med; 2019 Mar; 120():60-70. PubMed ID: 30659908
[TBL] [Abstract][Full Text] [Related]
57. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
[TBL] [Abstract][Full Text] [Related]
58. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
59. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
[No Abstract] [Full Text] [Related]
60. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
